ERBB2 and breast cancer: Higher responses were confined to patients with triple negative, HER2+, PD-L1+, BRCA1/2 deficient and treatment-naïve subgroups of BC patients, underlying the fact that person stratification is important for the optimisation of immune responses in BC patients [89,92,94].